Search results
Company News for Jun 24, 2024
Zacks via Yahoo Finance Canada· 7 days ago(SRPT) soared 30.1% following FDA’s approval for the expanded use of its gene therapy, Elevidys, for patients with Duchenne muscular dystrophy. Hertz ...
(SRPT) soared 30.1% following FDA’s approval for the expanded use of its gene therapy, Elevidys, for patients with Duchenne muscular dystrophy. Hertz ...